Clinical significance of disease‐specific MYD88 mutations in circulating DNA in primary central nervous system lymphoma

Recent sequencing studies demonstrated the MYD88 L265P mutation in more than 70% of primary central nervous system lymphomas (PCNSL), and the clinical significance of this mutation has been proposed as diagnostic and prognostic markers in PCNSL. In contrast, mutational analyses using cell‐free DNAs...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Sci
Autors principals: Hattori, Keiichiro, Sakata‐Yanagimoto, Mamiko, Suehara, Yasuhito, Yokoyama, Yasuhisa, Kato, Takayasu, Kurita, Naoki, Nishikii, Hidekazu, Obara, Naoshi, Takano, Shingo, Ishikawa, Eiichi, Matsumura, Akira, Hasegawa, Yuichi, Chiba, Shigeru
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2017
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5765295/
https://ncbi.nlm.nih.gov/pubmed/29151258
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13450
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars